MML Investors Services LLC bought a new position in Allogene Therapeutics, Inc. (NASDAQ:ALLO – Free Report) during the 3rd quarter, according to its most recent Form 13F filing with the Securities & ...

Beam Therapeutics Inc. (NASDAQ:BEAM – Get Free Report) has earned a consensus rating of “Moderate Buy” from the eleven analysts that are covering the stock, Marketbeat Ratings reports. Three ...

Bicistronic CAR T-cell therapy can produce durable complete responses in pediatric patients with relapsed or refractory B-ALL, data suggest.

Douglas Richmond is seeking compassionate due to his daughter's leukemia. But in Tennessee such a process doesn't exist.

A trio of experts discuss the treatment of chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL) with Bruton ...

This year’s most-read articles on chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL) explored treatment ...

CURE® highlights some top stories from the ASH Annual Meeting, focusing on B-cell acute lymphoblastic leukemia, multiple ...

GRAND TRAVERSE COUNTY, Mich., (WPBN/WGTU) - - "Leukemia is the most expensive cancer treatment on the planet," Tim Bergstrom ...

HealthDay News — For patients with relapsed or refractory B-cell acute lymphoblastic leukemia (ALL), obecabtagene autoleucel (obe-cel), an autologous 41BB-ζ anti-CD19 chimeric antigen receptor (CAR) T ...

Among patients with heavily pretreated chronic lymphocytic leukemia, treatment with Epkinly monotherapy showed deep responses ...

The global market for intraocular lymphoma therapy is expected to be worth USD 1.2 billion by the year of 2023. The market, ...

Six-year-old Bentley’s diagnosis of precursor B cell acute lymphocytic leukemia (B-ALL) in 2019 sent his family into a ...